JY
COCH icon

Jeff Yass’s Envoy Medical COCH Stock Holding History

Jeff Yass’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-35,297
Closed -$23.5K – 13518
2026
Q1 		$23.5K Sell
35,297
-83,818
-70% -$57.1K ﹤0.01% 12826
2025
Q4 		$78.7K Buy
+119,115
New +$94.3K ﹤0.01% 11574
2023
Q1 		– Sell
-61,474
Closed -$621K – 12655
2022
Q4 		$621K Hold
61,474
– – ﹤0.01% 7308
2022
Q3 		$604K Buy
+61,474
New +$604K ﹤0.01% 7976

Other funds holding COCH

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCA
DSG Capital Advisors Edina, Minnesota $704M AUM 34.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACP
Arcus Capital Partners Atlanta, Georgia $242M AUM 20.33% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

Jeff Yass's COCH Position: Q2 2026 in Review

Jeff Yass sold out of Envoy Medical (COCH) in Q2 2026, closing a stake of 35,297 shares — an estimated $23.5K sold.

Jeff Yass first reported a position in COCH in Q3 2022 and held it in 4 quarters. The position peaked at $621K in Q4 2022. 32 funds tracked by Wall St. Rank hold COCH as of Q2 2026.

  • Jeff Yass reported no remaining Envoy Medical position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 35,297 Envoy Medical shares in Q2 2026, an estimated $23.5K.
  • Jeff Yass first reported a position in Envoy Medical in Q3 2022 and held it in 4 quarters.
  • Jeff Yass's Envoy Medical position peaked at $621K in Q4 2022.
  • 32 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.